Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors

OSMANİYE D., TÜRKEŞ C., Demir Y., ÖZKAY Y., BEYDEMİR Ş., KAPLANCIKLI Z. A.

ARCHIV DER PHARMAZIE, cilt.355, sa.8, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 355 Sayı: 8
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1002/ardp.202200132
  • Dergi Adı: ARCHIV DER PHARMAZIE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, Chemical Abstracts Core, Chimica, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database, Index Chemicus (IC)
  • Anahtar Kelimeler: dithiocarbamate, hCA I, hCA II, methysulfonyl, molecular docking, ACCURATE DOCKING, IN-SILICO, GLIDE, BIOISOSTERISM, SULFONAMIDES, XII, IX
  • Anadolu Üniversitesi Adresli: Evet

Özet

Carbonic anhydrase (CA) enzymes are involved in many physiological events. These enzymes, which contain Zn2+ in their structure, can be easily inhibited by dithiocarbamate compounds. In addition, CA enzyme inhibitory activities are known in groups such as sulfonamide and methylsulfonyl. For this purpose, in this study, a series of 23 new dithiocarbamate-methylsulfonyl derivatives were synthesized and their CA enzyme inhibitory activities were investigated. The inhibition potentials of the obtained compounds against the human CA I and CA II enzymes were investigated by the in vitro enzyme isolation method. It is seen that the compounds show activity at the nanomolar level. Molecular docking studies of the compounds were carried out by in silico methods. The poses of compounds 2a, 2e, 2o, and 2t are presented.